Ticker > Company >

Makers Laboratories share price

Makers Laboratories Ltd.

BSE: 506919 SECTOR: Pharmaceuticals & Drugs  9490   8   0

173.80
+10.10 (6.17%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 176

Today's Low

₹ 160.3

52 Week High

₹ 190

52 Week Low

₹ 108.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

102.55 Cr.

Enterprise Value

116.06 Cr.

No. of Shares

0.59 Cr.

P/E

30.98

P/B

1.76

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  98.79

CASH

0.07 Cr.

DEBT

13.58 Cr.

Promoter Holding

61.27 %

EPS (TTM)

₹  5.61

Sales Growth

15.38%

ROE

-12.67 %

ROCE

-8.03%

Profit Growth

-9.29 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.38%
3 Year3.39%
5 Year1.04%

Profit Growth

1 Year-9.29%
3 Year-232.01%
5 Year-223.21%

ROE%

1 Year-12.67%
3 Year-8.01%
5 Year-5.55%

ROCE %

1 Year-8.03%
3 Year-4.33%
5 Year-2.39%

Debt/Equity

0.264

Price to Cash Flow

-33.49

Interest Cover Ratio

-3.2561

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 61.27 0.00
Jun 2024 61.27 0.00
Mar 2024 61.27 0.00
Dec 2023 61.27 0.00
Sep 2023 61.27 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 24.5998 days.
  • The company has a high promoter holding of 61.27%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 16.2913740826602.

 Limitations

  • The company has shown a poor profit growth of -232.006765469527% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.39390884055804% for the Past 3 years.
  • Company has a poor ROE of -8.01427634322513% over the past 3 years.
  • Company has a poor ROCE of -4.32507325005988% over the past 3 years
  • Company has low Interest coverage ratio of -3.2561.
  • Company has negative cash flow from operations of -3.0621.
  • Tax rate is low at 0.0848.
  • The company has a low EBITDA margin of 0.236896469380352% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 14.92 11.17 11.45 12.29 11.5
Total Expenditure 15.64 12.29 11.59 12.56 11.67
Operating Profit -0.72 -1.12 -0.14 -0.27 -0.17
Other Income 0.69 0.12 0.15 0.14 10.19
Interest 0.41 0.42 0.46 0.39 0.33
Depreciation 0.68 0.68 0.68 0.72 0.71
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.11 -2.1 -1.14 -1.24 8.98
Tax -0.12 -0.15 0.42 -0.02 0.95
Profit After Tax -0.99 -1.95 -1.56 -1.22 8.03
Adjusted EPS (Rs) -1.68 -3.3 -2.64 -2.07 13.62

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 51.4 44.41 52.38 42.55 49.09
Total Expenditure 48.68 41.1 49.32 46.68 52.85
Operating Profit 2.72 3.31 3.05 -4.13 -3.76
Other Income 0.23 0.41 0.85 1.14 1.15
Interest 0.7 1.6 1.68 1.38 1.63
Depreciation 1.99 4.2 1.91 2.4 2.71
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.25 -2.07 0.31 -6.78 -6.96
Tax 0.37 -0.46 0.14 -0.41 -0.01
Net Profit -0.12 -1.62 0.17 -6.36 -6.95
Adjusted EPS (Rs.) -0.24 -3.15 0.35 -10.78 -11.78

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.92 4.92 4.92 5.9 5.9
Total Reserves 39.7 44.7 45.38 52.38 45.55
Borrowings 5.98 5.53 2.69 2.39 6
Other N/C liabilities 3.91 2.9 2.79 3.2 2.96
Current liabilities 19.36 21.07 29.71 20.91 25.73
Total Liabilities 73.87 79.12 85.48 84.79 86.15
Assets
Net Block 32.89 30.59 29.94 40.45 39.88
Capital WIP 0.67 0.12 8.94 0.01 0
Intangible WIP 0.02 0 0 0.03 0
Investments 15.04 23.66 22.55 22.52 22.56
Loans & Advances 1.46 1.5 2.69 2.58 2.83
Other N/C Assets 0.04 0.04 0.01 0.04 0.03
Current Assets 23.77 23.2 21.35 19.16 20.85
Total Assets 73.87 79.12 85.48 84.79 86.15
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.25 -2.07 0.31 -6.78 -6.96
Adjustment 2.9 5.47 3.29 3.33 3.64
Changes in Assets & Liabilities 1.11 -1.35 3.75 2.42 0.57
Tax Paid -0.04 -1.38 -0.55 -0.4 -0.32
Operating Cash Flow 4.23 0.67 6.8 -1.42 -3.06
Investing Cash Flow -8.43 -2.65 -8.78 -3.55 -2.04
Financing Cash Flow 2.91 1.37 1.77 4.94 5.12
Net Cash Flow -1.29 -0.61 -0.21 -0.04 0.02

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 61.27 61.27 61.27 61.27 61.27
bhawna godha 0.72 0.72 0.72 0.72 0.72
chandurkar investments pr... 1.43 1.43 1.43 1.43 1.43
kaygee investments privat... 17.38 17.38 17.38 17.38 17.38
kaygee laboratories priva... 14.35 14.35 14.35 14.35 14.35
mexin medicaments private... 3.12 3.12 3.12 3.12 3.12
nirmal gigalal jain 1.62 1.62 1.62 1.62 1.62
paschim chemicals pvt ltd... 16.38 16.38 16.38 16.38 16.38
prashant godha 2.08 2.08 2.08 2.08 2.08
premchand godha 2.15 2.15 2.15 2.15 2.15
sameer m chandurkar 0.37 0.37 0.37 0.37 0.37
usha m chandurkar 0.69 0.69 0.69 0.69 0.69
usha premchand godha 0.97 0.97 0.97 0.97 0.97
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 38.73 38.73 38.73 38.73 38.73
achyutkumar ratilal modi 1.07 1.07 1.07 1.07 1.07
investor education and pr... - - - 2.57 2.57
kiran rashmin rughani - - - - 1.15
llp 0.02 0.02 0.05 0.03 0.03
tanvi jignesh mehta - - 1.25 1.76 2.16
vishal jain - 0.13 0.13 0.13 0.13
investor education and pr... 2.58 2.58 2.58 - -

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Makers Laboratories - Quaterly Results 29 Oct, 12:00 PM Makers Laboratories - Quaterly Results 29 Oct, 12:00 PM Makers Laboratories - Quaterly Results 29 Oct, 12:00 PM Makers Laboratories - Quaterly Results 6 Aug, 11:15 AM Makers Laboratories - Quaterly Results 6 Aug, 11:15 AM Makers Laboratories - Quaterly Results 6 Aug, 11:15 AM Makers Laboratories Informs about press release 11 Jul, 2:40 PM Makers Laboratories informs about annual report 10 Jul, 12:21 PM Makers Laboratories - Quaterly Results 23 May, 1:14 PM Makers Laboratories - Quaterly Results 23 May, 1:14 PM Makers Laboratories - Quaterly Results 23 May, 1:14 PM Makers Laboratories submits financial results 13 Feb, 2:02 PM Makers Laboratories - Quaterly Results 13 Feb, 12:16 PM Makers Laboratories - Quaterly Results 13 Feb, 12:16 PM Makers Laboratories - Quaterly Results 13 Feb, 12:16 PM Makers Laboratories informs about compliances-certificate 11 Jan, 1:02 PM Makers Laboratories informs about loss of share certificate 20 Dec, 3:13 PM Makers Laboratories informs about loss of share certificate 4 Dec, 11:49 AM Makers Laboratories - Quaterly Results 7 Nov, 12:39 PM Makers Laboratories - Quaterly Results 7 Nov, 12:39 PM Makers Laboratories - Quaterly Results 7 Nov, 12:39 PM Makers Laboratories informs about disclosure 4 Oct, 5:26 PM Makers Laboratories informs about outcome of board meeting 14 Aug, 12:27 PM Makers Laboratories - Quaterly Results 14 Aug, 11:02 AM Makers Laboratories informs about loss of share certificate 9 Aug, 12:15 PM Makers Laboratories informs about loss of share certificate 21 Jul, 2:25 PM Makers Laboratories - Quaterly Results 22 May, 1:33 PM Makers Laboratories - Quaterly Results 22 May, 1:33 PM Makers Laboratories - Quaterly Results 22 May, 1:33 PM Makers Laboratories informs about compliance certificate 12 Apr, 4:50 PM Makers Laboratories submits unaudited financial results 13 Feb, 4:16 PM Makers Laboratories - Quaterly Results 13 Feb, 12:28 PM Makers Laboratories - Quaterly Results 13 Feb, 12:28 PM Makers Laboratories - Quaterly Results 13 Feb, 12:28 PM Makers Laboratories informs about board meeting 19 Oct, 3:45 PM Makers Laboratories informs about loss of share certificates 26 Sep, 2:52 PM Makers Laboratories informs about newspaper publication 16 Aug, 2:42 PM Makers Laboratories - Quaterly Results 14 Aug, 10:22 AM Makers Laboratories - Quaterly Results 14 Aug, 10:22 AM Makers Laboratories - Quaterly Results 14 Aug, 10:22 AM Makers Laboratories informs about newspaper publication 18 Jul, 10:18 AM Makers Laboratories - Quaterly Results 27 May, 1:02 PM Makers Laboratories informs about board meeting 17 May, 4:53 PM Makers Laboratories informs about outcome of board meeting 6 May, 12:57 PM Makers Laboratories informs about compliance certificate 24 Mar, 4:45 PM Makers Laboratories - Quaterly Results 9 Feb, 12:14 PM Makers Laboratories - Quaterly Results 9 Feb, 12:14 PM Makers Laboratories - Quaterly Results 9 Feb, 12:14 PM Makers Laboratories gets nod to raise Rs 14.75 crore 10 Nov, 4:10 PM Makers Laboratories informs about outcome of AGM 19 Aug, 3:16 PM

Makers Laboratories Stock Price Analysis and Quick Research Report. Is Makers Laboratories an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Makers Laboratories and its performance over the period of time. Makers Laboratories stock price today is Rs 173.8.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Makers Laboratories cash from the operating activity was Rs -3.0621 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Makers Laboratories has a Debt to Equity ratio of 0.264 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Makers Laboratories , the EPS growth was -9.2908 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Makers Laboratories has OPM of -7.66004257616346 % which is a bad sign for profitability.
     
  • ROE: Makers Laboratories have a poor ROE of -12.6707 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Makers Laboratories is Rs 173.8. One can use valuation calculators of ticker to know if Makers Laboratories share price is undervalued or overvalued.
Last Updated on:
Brief about Makers Laboratories
X